Biophysics of Protein-Mediated Membrane Fusion
蛋白质介导的膜融合的生物物理学
基本信息
- 批准号:8728255
- 负责人:
- 金额:$ 35.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsBiological AssayBiophysicsCCR5 geneCD4 Positive T LymphocytesCXCR4 geneCell LineCell fusionCell membraneCell surfaceCellsChimeric ProteinsClathrinComplexCytoplasmCytoskeletonCytosolCytosolic Phospholipase A2DataDependenceDepositionDynaminEndocytosisEndosomesFluorescence Resonance Energy TransferGenomeGoalsHIVHIV-1HIV-2ImageInfectionInfluenzaIntegration Host FactorsLabelLasersLateralLeadLifeLipidsLymphoid CellMediatingMembraneMembrane FusionModelingNucleocapsidPathway interactionsPharmaceutical PreparationsPhospholipasePlayProcessPropertyProteinsReactionRelative (related person)RelianceReportingResistanceResourcesRoleRouteSiteStagingSurfaceTechniquesTestingTherapeutic InterventionViralVirionVirusbasecell typecellular targetingenv Glycoproteinsfollow-upimprovedinhibitor/antagonistinnovationknock-downnovelrab GTP-Binding Proteinsreceptorresearch studystemtraffickinguptake
项目摘要
DESCRIPTION (provided by applicant): The Human Immunodeficiency Virus (HIV) has long been thought to enter target cells by fusing with the plasma membrane. This notion is based, in part, on the fact that the HIV Env glycoprotein engages CD4 and coreceptors, CCR5 or CXCR4, on the cell surface and then promotes membrane fusion by undergoing pH- independent conformational changes. Our recent study has challenged this view by presenting direct evidence for HIV entry via an endocytic pathway. The arguments for this entry route are based on: (i) the delayed release of HIV content into the cytosol relative to the acquisition of resistane to a membrane-impermeant fusion inhibitor; and (ii) single HIV imaging which reveals complete fusion with endosomes but only partial fusion at the cell surface. However, the notion of HIV entry via endocytosis has not been widely accepted in the field. We therefore propose to carefully evaluate the HIV entry routes in different cell types and define the viral and cellular determinants of the sites of HIV fusion. Our central hypothesis is that HIV can promote only the early steps of fusion, while relying on the host cell to complete this process. This hypothesis stems from the idea that a handful of Env on HIV particles may not be sufficient to overcome a large energy barrier associated with creating the highly unfavorable lipid intermediates en route to fusion. The proposed model makes testable predictions that will guide our quest for the host factors that can aid the HIV fusion. We will: 1. Examine the Env- and cell type-dependence of HIV entry routes. The HIV fusion sites in lymphoid cell lines and primary CD4+ T cells will be defined using an improved single virus imaging approach. 2. Determine whether complete HIV fusion with the plasma membrane requires an external force. We will evaluate the dependence of HIV-cell fusion and of HIV-mediated cell-cell fusion on actin remodeling which can generate lateral membrane tension and thereby promote the dilation of a fusion pore. 3. Explore cellular factors responsible for HIV fusion with endosomes. We will follow up on our pilot data implicating several host proteins in HIV trafficking and fusion. A common feature of the selected host factors is that they generate a membrane curvature or modify the lipid composition and can thus favor HIV-endosome fusion. The proposed studies will define the HIV entry and fusion pathways. We expect to elucidate the extent of virus' reliance on host factors and delineate the mechanism of complete HIV fusion that culminates in the release of the nucleocapsid.
描述(由申请人提供):人类免疫缺陷病毒(HIV)一直被认为是通过与质膜融合进入靶细胞的。这一观点部分是基于这样一个事实,即HIV Env糖蛋白与细胞表面的CD4和辅助受体CCR5或CXCR4结合,然后通过发生与pH无关的构象变化促进膜融合。我们最近的研究通过提供HIV通过内吞途径进入的直接证据挑战了这一观点。这种进入途径的论点是基于:(i)相对于获得对膜外融合抑制剂的抗性,HIV内容物延迟释放到细胞质中;(ii)单个HIV成像,显示与核内体完全融合,但仅在细胞表面部分融合。然而,艾滋病毒通过内吞作用进入的概念在该领域尚未被广泛接受。因此,我们建议仔细评估HIV在不同细胞类型中的进入途径,并确定HIV融合位点的病毒和细胞决定因素。我们的中心假设是,HIV只能促进融合的早期步骤,而依靠宿主细胞来完成这一过程。这一假设源于这样一种观点,即HIV颗粒上的少量Env可能不足以克服与在融合过程中产生高度不利的脂质中间体相关的巨大能量屏障。提出的模型做出了可测试的预测,这将指导我们寻找有助于HIV融合的宿主因子。我们将:1;检查HIV进入途径的环境和细胞类型依赖性。淋巴样细胞系和原发CD4+ T细胞中的HIV融合位点将使用改进的单病毒成像方法来确定。2. 确定HIV与质膜的完全融合是否需要外力。我们将评估hiv -细胞融合和hiv介导的细胞-细胞融合对肌动蛋白重塑的依赖性,肌动蛋白重塑可以产生侧膜张力,从而促进融合孔的扩张。3. 探索负责HIV与核内体融合的细胞因子。我们将跟进我们的试点数据,涉及艾滋病毒贩运和融合的几种宿主蛋白。所选宿主因子的一个共同特征是它们产生膜曲率或修改脂质组成,从而有利于hiv内体融合。所提出的研究将确定HIV的进入和融合途径。我们希望阐明病毒对宿主因子的依赖程度,并描绘出在核衣壳释放中达到高潮的HIV完全融合的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory B Melikian其他文献
Gregory B Melikian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory B Melikian', 18)}}的其他基金
Molecular Interactions of HIV-1 with the Nuclear Pore Complex
HIV-1 与核孔复合物的分子相互作用
- 批准号:
10241258 - 财政年份:2019
- 资助金额:
$ 35.1万 - 项目类别:
Molecular Interactions of HIV-1 with the Nuclear Pore Complex
HIV-1 与核孔复合物的分子相互作用
- 批准号:
10462620 - 财政年份:2019
- 资助金额:
$ 35.1万 - 项目类别:
Inhibition of viral entry by interferon-induced proteins
干扰素诱导蛋白抑制病毒进入
- 批准号:
10418696 - 财政年份:2018
- 资助金额:
$ 35.1万 - 项目类别:
Inhibition of viral entry by interferon-induced proteins
干扰素诱导蛋白抑制病毒进入
- 批准号:
10190798 - 财政年份:2018
- 资助金额:
$ 35.1万 - 项目类别:
Imaging of Single HIV-1 Uncoating and Transport to the nucleus
单个 HIV-1 脱壳和转运至细胞核的成像
- 批准号:
9354023 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
Functional Characterization of the Hepatitis C Virus E1-E2 Glycoproteins
丙型肝炎病毒 E1-E2 糖蛋白的功能表征
- 批准号:
7522862 - 财政年份:2009
- 资助金额:
$ 35.1万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 35.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 35.1万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 35.1万 - 项目类别:
Postdoctoral Fellowships














{{item.name}}会员




